The challenge for the next few years will be to individualize prostate cancer treatment and to determine whether or not a cancer will be lethal based on molecular characteristics at the time of diagnosis.
In this view, the need for active treatment would represent a failure of any conservative approach.
Written by:
Gandaglia G, Giannarini G, Suardi N, Montorsi F, Briganti A. Are you the author?
Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Department of Urology, University of Bern, Inselspital, Bern, Switzerland.
Reference: Eur Urol. 2014 May 13. pii: S0302-2838(14)00401-1.
doi: 10.1016/j.eururo.2014.04.020
PubMed Abstract
PMID: 24836154
UroToday.com Prostate Cancer Section
